Publicaciones en las que colabora con Miguel Ángel Abellanas Sánchez (10)

2020

  1. Cannabinoid receptor type 2 as a therapeutic target for Parkinson’s disease

    Diagnosis and Management in Parkinson’s Disease: The Neuroscience of Parkinson’s Disease, Volume 1 (Elsevier), pp. 557-573

  2. Cb2 receptors and neuron–glia interactions modulate neurotoxicity generated by magl inhibition

    Biomolecules, Vol. 10, Núm. 8, pp. 1-15